Drug Shortage Report for KEVZARA
Report ID | 155759 |
Drug Identification Number | 02472988 |
Brand name | KEVZARA |
Common or Proper name | Kevzara |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | SARILUMAB |
Strength(s) | 200MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | 2 |
ATC code | L04AC |
ATC description | IMMUNOSUPPRESSANTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2022-03-21 |
Actual start date | |
Estimated end date | 2022-06-01 |
Actual end date | 2022-05-30 |
Shortage status | Resolved |
Updated date | 2022-05-31 |
Company comments | Manufacturing delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v14 | 2022-05-31 | English | Compare |
v13 | 2022-05-30 | French | Compare |
v12 | 2022-05-30 | English | Compare |
v11 | 2022-05-30 | French | Compare |
v10 | 2022-05-30 | English | Compare |
v9 | 2022-05-16 | French | Compare |
v8 | 2022-05-16 | English | Compare |
v7 | 2022-04-25 | French | Compare |
v6 | 2022-04-25 | English | Compare |
v5 | 2022-03-22 | English | Compare |
v4 | 2022-03-01 | French | Compare |
v3 | 2022-03-01 | English | Compare |
v2 | 2022-03-01 | French | Compare |
v1 | 2022-03-01 | English | Compare |
Showing 1 to 14 of 14